According to Gen Consulting Company, the global real-world evidence solutions market size is expected to increase from USD 977 million in 2021 to USD 2,371 million by 2028, garnering a CAGR of 13.5% over the evaluated period.
This industry report offers market estimates of the global market, followed by a detailed analysis of the component, therapeutic area, end user, and region. The global market data on real-world evidence solutions can be segmented by component: data sets, services. Real-world evidence solutions market is further segmented by therapeutic area: cardiovascular disease, immunology, neurology, oncology, others. Based on end user, the real-world evidence solutions market is segmented into: healthcare payers, healthcare providers, pharmaceutical & medical device companies, others. On the basis of region, the real-world evidence solutions market also can be divided into: North America, Europe, Asia-Pacific, Rest of the World.
The global real-world evidence solutions market is highly competitive. The competitive landscape of the industry has also been examined along with the profiles of the key players Accenture plc, Clinigen Group Plc, COTA Inc., IBM Corporation, ICON plc, IQVIA Inc., Optum Inc., Oracle Corporation, Parexel International Corporation, PerkinElmer Inc., PPD Inc., Saama Technologies LLC., SAS Institute Inc., Syneos Health Inc., Tempus Labs Inc.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
– Get a detailed picture of the Global Real-World Evidence Solutions Market
– Identify segments/areas to invest in over the forecast period in the Global Real-World Evidence Solutions Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 13.5% |
| Pages | 24 |
| Key Players | Accenture plc, Clinigen Group Plc, COTA Inc., IBM Corporation, ICON plc, IQVIA Holdings Inc., Optum Inc., Oracle Corporation, Parexel International Corporation, PerkinElmer Inc., PPD Inc., Saama Technologies LLC., SAS Institute Inc., Syneos Health Inc., Tempus Labs Inc. |
The skin care and treatment market in China, in terms of revenue, is expected to grow by 9.9 percent annually through 2029, according to the latest estimates. Skin care is essential for maintaining skin health and preventing skin conditions. It helps to protect the skin from environmental factors, such as…
According to the latest research, the skin-related beauty market in China is estimated to increase at the rate of 10.1% each year in the period from 2023 to 2029. Skin-related beauty refers to the products and treatments aimed at improving the health, appearance, and overall condition of the skin. It…
Global suction catheter market by product (closed suction catheter, open suction catheter), by region (Asia-Pacific, Europe, North America, Middle East and Africa (MEA), South America), outlook & forecast, 2023-2029
Please fill out our form and we will get back to you.